The predictive value of liver tests for the presence of liver metastases
© 2023 The Authors..
Aim: To analyze the predictive value of biochemical liver tests in patients with malignant melanoma, breast, colorectal or lung cancers at the time of diagnosis of liver metastases.
Methods: A retrospective review of patients with the above-mentioned solid tumors at MedStar Georgetown University Hospital from 2016-2020.
Results: The highest optimal cutoff according to sensitivity and specificity for the presence of liver metastases was for AST ≥1.5 × ULN for melanoma, lung, and breast cancers and ≥2 × ULN for colorectal cancer, ALT ≥1.25 × ULN for melanoma, breast and colorectal cancers and ≥1.5 × ULN for lung cancer, and ALP ≥1.5 × ULN for melanoma, breast and colorectal cancers.
Conclusion: Using thresholds of liver enzymes above the ULN may improve the diagnostic accuracy for the presence of liver metastases.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Hepatic oncology - 10(2023), 3 vom: 23. Sept., Seite HEP48 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kimchy, Alexandra V [VerfasserIn] |
---|
Links: |
---|
Themen: |
Breast neoplasms |
---|
Anmerkungen: |
Date Revised 28.10.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.2217/hep-2023-0003 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM363776761 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM363776761 | ||
003 | DE-627 | ||
005 | 20231226094050.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2217/hep-2023-0003 |2 doi | |
028 | 5 | 2 | |a pubmed24n1212.xml |
035 | |a (DE-627)NLM363776761 | ||
035 | |a (NLM)37885607 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kimchy, Alexandra V |e verfasserin |4 aut | |
245 | 1 | 4 | |a The predictive value of liver tests for the presence of liver metastases |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 28.10.2023 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2023 The Authors. | ||
520 | |a Aim: To analyze the predictive value of biochemical liver tests in patients with malignant melanoma, breast, colorectal or lung cancers at the time of diagnosis of liver metastases | ||
520 | |a Methods: A retrospective review of patients with the above-mentioned solid tumors at MedStar Georgetown University Hospital from 2016-2020 | ||
520 | |a Results: The highest optimal cutoff according to sensitivity and specificity for the presence of liver metastases was for AST ≥1.5 × ULN for melanoma, lung, and breast cancers and ≥2 × ULN for colorectal cancer, ALT ≥1.25 × ULN for melanoma, breast and colorectal cancers and ≥1.5 × ULN for lung cancer, and ALP ≥1.5 × ULN for melanoma, breast and colorectal cancers | ||
520 | |a Conclusion: Using thresholds of liver enzymes above the ULN may improve the diagnostic accuracy for the presence of liver metastases | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a breast neoplasms | |
650 | 4 | |a colonic neoplasms | |
650 | 4 | |a liver biochemical tests | |
650 | 4 | |a liver metastases | |
650 | 4 | |a lung neoplasms | |
650 | 4 | |a malignant melanoma | |
700 | 1 | |a Singh, Harjit |e verfasserin |4 aut | |
700 | 1 | |a Parikh, Esha |e verfasserin |4 aut | |
700 | 1 | |a Rosenberg, Jessica |e verfasserin |4 aut | |
700 | 1 | |a Sanghavi, Kavya |e verfasserin |4 aut | |
700 | 1 | |a Lewis, James H |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Hepatic oncology |d 2014 |g 10(2023), 3 vom: 23. Sept., Seite HEP48 |w (DE-627)NLM237741474 |x 2045-0931 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2023 |g number:3 |g day:23 |g month:09 |g pages:HEP48 |
856 | 4 | 0 | |u http://dx.doi.org/10.2217/hep-2023-0003 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2023 |e 3 |b 23 |c 09 |h HEP48 |